الوصف

Comprehensive supplementary data from the melatonin-prostate cancer study, including additional statistical analyses and experimental replicates.

Figure 36

Chart

Source Paper

Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.

Clinical and translational medicine (2021)

PMID: 34185414

DOI: 10.1002/ctm2.449

Cite This Figure

![Figure 36: Comprehensive supplementary data from the melatonin-prostate cancer study, including additional statistical analyses and experimental replicates.]()

> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)

<figure>
  <img src="" alt="Comprehensive supplementary data from the melatonin-prostate cancer study, including additional statistical analyses and experimental replicates." />
  <figcaption>Figure 36. Comprehensive supplementary data from the melatonin-prostate cancer study, including additional statistical analyses and experimental replicates.<br>  Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption>
</figure>

أدلة ذات صلة

Melatonin لـ اضطراب الإيقاع اليوماوي

التقييم A · 176 دراسات